Tolerability of Ig20Gly During Onboarding in Patients With Primary Immunodeficiency Diseases.

CONCLUSION: High Ig20Gly infusion rates ≥60 mL/h/site and volumes ≥60 mL/site were well tolerated during onboarding and throughout treatment regardless of prestudy treatment. PMID: 31228628 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31228628?dopt=Abstract

Source: Annals of Allergy, Asthma and Immunology - June 18, 2019 Category: Allergy & Immunology Authors: Gupta S, Stein M, Hussain I, Paris K, Engl W, McCoy B, Rabbat CJ, Yel L Tags: Ann Allergy Asthma Immunol Source Type: research